Ultra Market Research | United states (U.S.)Coronary Artery Bypass Graft Market
United states (U.S.)Coronary Artery Bypass Graft Market
Report ID : 845
Category : Healthcare-Services,United-States(US)
No Of Pages : 122
Published on: November 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Introduction
The United States Coronary Artery Bypass Graft (CABG) Market is a crucial segment of the cardiovascular healthcare sector, addressing the surgical treatment of coronary artery disease (CAD). CABG procedures involve rerouting blood around blocked arteries to restore proper blood flow to the heart, significantly improving patient outcomes. The market is experiencing growth driven by the increasing prevalence of cardiovascular diseases, an aging population, and advancements in minimally invasive surgical techniques. Emerging trends include the adoption of hybrid revascularization procedures and robotic-assisted CABG surgeries, enhancing precision and patient recovery. With the rising awareness about cardiovascular health and innovative medical technologies, the United States CABG market continues to evolve, offering improved solutions for critical heart conditions.
Segmentation
By Product Surgical Instruments
Cannulas
Retractors
Others
Grafts
Arterial Grafts
Venous Grafts
Synthetic Grafts
Others
Pumps
Beating Heart Surgery Pumps
Cardiopulmonary Bypass Pumps
Others
By Procedure On-Pump Coronary Artery Bypass Grafting
Traditional CABG
Sequential Grafting
Others
Off-Pump Coronary Artery Bypass Grafting
MIDCAB
Hybrid CABG
Others
By End-User Hospitals
Public Hospitals
Private Hospitals
Specialty Clinics
Cardiac Clinics
Multi-Specialty Clinics
Ambulatory Surgical Centers
List of Market Players
Medtronic (United States)
Johnson & Johnson (United States)
Edwards Lifesciences (United States)
Boston Scientific Corporation (United States)
Abbott Laboratories (United States)
Terumo Corporation (Japan)
B. Braun Melsungen AG (Germany)
W. L. Gore & Associates (United States)
Zimmer Biomet (United States)
CryoLife Inc. (United States)
Getinge AB (Sweden)
Smith & Nephew (United Kingdom)
Artivion, Inc. (United States)
LeMaitre Vascular, Inc. (United States)
Genesee BioMedical (United States)
Drivers
The United States Coronary Artery Bypass Graft Market is propelled by a significant rise in cardiovascular disease prevalence, driven by sedentary lifestyles, obesity, and unhealthy dietary habits. The aging population also contributes to market growth, as older individuals are more susceptible to coronary artery diseases. Advances in surgical techniques, including robotic-assisted CABG and hybrid revascularization procedures, have increased patient confidence in these surgeries. Government initiatives aimed at reducing cardiovascular disease mortality rates further support the market. Additionally, the development of bioengineered grafts with enhanced compatibility and reduced rejection rates has attracted attention, expanding therapeutic options and boosting the market.
Restraints
Challenges hindering the growth of the United States CABG market include the high cost of surgical procedures and equipment, limiting accessibility for uninsured or underinsured populations. The increasing adoption of alternative treatments like angioplasty and stenting also poses a challenge, as they are less invasive and often preferred by patients and physicians. The market faces constraints due to limited availability of skilled cardiovascular surgeons, particularly in rural areas. Moreover, risks associated with CABG surgeries, such as infections and postoperative complications, can deter potential candidates, further impacting market growth.
Opportunities
The market presents numerous growth opportunities, particularly with technological advancements in minimally invasive and robotic-assisted CABG surgeries. Growing investment in R&D for bioengineered grafts and synthetic solutions is anticipated to enhance treatment outcomes and patient safety. The integration of artificial intelligence and machine learning in surgical planning and execution offers improved precision and efficiency. Expanding healthcare infrastructure in underserved areas and increasing insurance coverage for cardiovascular procedures open up untapped potential. Furthermore, collaborations between healthcare providers and technology firms to develop cost-effective surgical instruments and grafts are expected to drive market expansion.
Trends
The United States CABG market is witnessing several trends, including the shift toward hybrid revascularization techniques combining CABG and stenting, providing better outcomes for complex cases. Robotic-assisted surgeries are gaining traction for their precision and shorter recovery periods. The adoption of disposable surgical instruments to minimize infection risks is also notable. Another trend is the increasing use of biocompatible and drug-eluting grafts, enhancing long-term success rates. Additionally, augmented reality (AR) and virtual reality (VR) technologies are being employed for surgical training and planning, further advancing the field.
Key Target Audience
Hospitals and healthcare providers
Cardiologists and cardiovascular surgeons
Medical device manufacturers
Research institutions and universities
Regulatory bodies and healthcare policymakers
FAQs
The market encompasses products and procedures related to CABG surgeries in the United States, focusing on treating coronary artery diseases.
Key drivers include rising cardiovascular disease prevalence, advancements in surgical techniques, and growing demand for minimally invasive procedures.
High surgical costs, competition from alternative treatments, and risks associated with surgeries are notable restraints.
Key players include Medtronic, Johnson & Johnson, Abbott Laboratories, and Terumo Corporation.
Technological advancements, bioengineered grafts, and expanding healthcare infrastructure provide significant growth opportunities.
Executive Summary
Overview of the United States Coronary Artery Bypass Graft Market
Key Findings
Market Size and Growth Trends
Introduction
Definition and Scope
Applications in Cardiovascular Healthcare
Recent Trends
Market Segmentation
By Product
Surgical Instruments
Grafts
Pumps
By Procedure
On-Pump Coronary Artery Bypass Grafting
Off-Pump Coronary Artery Bypass Grafting
By End-User
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Competitive Landscape
List of Key Market Players
Medtronic (United States)
Johnson & Johnson (United States)
Edwards Lifesciences (United States)
Boston Scientific Corporation (United States)
Abbott Laboratories (United States)
Terumo Corporation (Japan)
B. Braun Melsungen AG (Germany)
W. L. Gore & Associates (United States)
Zimmer Biomet (United States)
CryoLife Inc. (United States)
Getinge AB (Sweden)
Smith & Nephew (United Kingdom)
Artivion, Inc. (United States)
LeMaitre Vascular, Inc. (United States)
Genesee BioMedical (United States)
Company Profiles
Overview
Key Developments
Market Dynamics
Drivers
Restraints
Opportunities
Trends
Key Target Audience
Hospitals and Healthcare Providers
Cardiologists and Surgeons
Medical Device Manufacturers
Regional Insights
Geographic Analysis of the United States
FAQs
Frequently Asked Questions About the Market
List of Tables
Table 1: United States Coronary Artery Bypass Graft Market Segmentation by Product
Table 2: Market Segmentation by Procedure and Sub-Procedures
Table 3: United States CABG Market Segmentation by End-User
Table 4: Key Companies Operating in the Market
Table 5: Market Drivers and Restraints Analysis
Table 6: Emerging Opportunities in the CABG Market
Table 7: Trends Transforming the United States CABG Market
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of United states (U.S.)Coronary Artery Bypass Graft Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of United states (U.S.)Coronary Artery Bypass Graft Market for the past year and forecasts for the next six years. United states (U.S.)Coronary Artery Bypass Graft Market. Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different United states (U.S.)Coronary Artery Bypass Graft Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for United states (U.S.)Coronary Artery Bypass Graft Market from different application industries in different regions.
Segmentation
By Product Surgical Instruments
Cannulas
Retractors
Others
Grafts
Arterial Grafts
Venous Grafts
Synthetic Grafts
Others
Pumps
Beating Heart Surgery Pumps
Cardiopulmonary Bypass Pumps
Others
By Procedure On-Pump Coronary Artery Bypass Grafting
